equate mucus d
- Product NDC
- 79903-125
- Requested package NDC
- 79903-125-18
- 11-digit product format
- 799030125
- Labeler code
- 79903
- Product ID
- 79903-125_55f4f941-8aad-4683-81e2-ef3d007a33a0
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- guaifenesin and pseudoephedrine hydrochloride
- Dosage form
- TABLET, MULTILAYER, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- WALMART INC.
- Application
- ANDA214407
- Marketing category
- ANDA
- Marketing start
- 2022-10-01
- Substance
- GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 600; 60 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 79903-125 | 79903-125-18 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | ||
| A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | bb7c543d1eb4… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A214407-001 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 600MG;60MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A214407-002 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1.2GM;120MG | TABLET, EXTENDED RELEASE / ORAL | 2022-02-01 | 1c564ffb4f44… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- equate mucus d
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 600 mg/1 |
| PSEUDOEPHEDRINE HYDROCHLORIDE | 60 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
| 6V9V2RYJ8N | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1305603 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0d5f6e14-5e42-494b-be1f-a46731007a0d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| e974e22d-8688-7d92-1e87-40c1079e170c | Product name | 3 | 20151125 |
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
| 30c51294-7ae9-8007-7de6-58222684a0be | Product name | 1 | 20140508 |
| 4f26f669-fc6c-40ef-9e26-1c7b2390ee66 | Product name | 1 | 20140508 |
| 70a83adc-6047-bbea-5a08-dfd304aa47d2 | Product name | 1 | 20140508 |
| 858ce051-9941-aafc-8c7c-44a8e0227463 | Product name | 1 | 20140508 |
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 79903-125-18 | equate mucus d | 1 in 1 CARTON | TABLET, MULTILAYER, EXTENDED REL | 1 | 2 | |
| 79903-125-18 | equate mucus d | 18 in 1 BLISTER PACK | TABLET, MULTILAYER, EXTENDED REL | 18 | 2 | |
| 79903-125-36 | equate mucus d | 18 in 1 BLISTER PACK | TABLET, MULTILAYER, EXTENDED REL | 18 | 2 | |
| 79903-125-36 | equate mucus d | 2 in 1 CARTON | TABLET, MULTILAYER, EXTENDED REL | 2 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 79903-125-18 | EA - Each | 79903-125 | 41bfcb28-8e66-40eb-a345-d0040d07b176 | 1 | 2024-09-09 |
| 79903-125-36 | EA - Each | 79903-125 | 204c4c80-39bf-4117-96fe-ca180d447dde | 1 | 2025-06-13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 79903-125 | EQUATE MUCUS D (GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET, MULTILAYER, EXTENDED RELEASE [WALMART INC.] | 1 | Current NDC, Legacy NDC, 4 package rows | 20221021_0d5f6e14-5e42-494b-be1f-a46731007a0d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Mucus Relief D | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | Cardinal Health 110, LLC. dba Leader | 12971fb2-2314-4443-bf70-b7eb5859b148 | 2026-05-26 | Warnings | 214407 ANDA214407 |
| mucus d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Kroger Company | 5065f07d-2130-4c84-a64a-dc27ef9cb92e | 2026-04-09 | Warnings | 214407 ANDA214407 |
| nasal and chest decongestant | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | Publix Super Markets Inc | 657aeccc-4f6a-496b-9a69-e64a81e4c91e | 2026-04-02 | Warnings | 214407 ANDA214407 |
| equate mucus d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | WALMART INC. | 0d5f6e14-5e42-494b-be1f-a46731007a0d | 2026-03-19 | Warnings | 214407 ANDA214407 79903-125-18 79903-125 79903012518 |
| mucus d | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | c8026a56-4249-48de-b763-2d1c55731733 | 2026-02-26 | Warnings | 214407 ANDA214407 |
| mucus relief d | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | Walgreen Company | 440c0cf6-d63d-4523-b137-26f70adb977a | 2026-02-07 | Warnings | 214407 ANDA214407 |
| foster and thrive mucus relief d | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | Strategic Sourcing Services LLC | 235a465c-3a5e-4775-92e9-e57fd8d9c9b4 | 2026-02-07 | Warnings | 214407 ANDA214407 |
| mucus relief d | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | H E B | 80acd350-7c96-4620-bd7c-848c85f157ed | 2026-01-27 | Warnings | 214407 ANDA214407 |
| EQUATE MUCUS D | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | WALMART INC. | 1ce50a5b-060d-4fb4-ba91-e62fccf9d5f9 | 2026-01-08 | Warnings | 214407 ANDA214407 |
| Mucus D | GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE | L. Perrigo Company | 86993cd9-5d55-4a70-8a33-701d91482292 | 2025-10-03 | Warnings | 214407 ANDA214407 |
| mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | L. Perrigo Company | db6ada8a-1799-4d35-8bda-4a322fbd7a06 | 2025-10-03 | Warnings | 214407 ANDA214407 |
| mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Meijer, Inc. | 5d0c5ded-cf78-4c42-8dc0-8d546884871f | 2025-06-10 | Warnings | 214407 ANDA214407 |
| MUCUS D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 59bce49c-25c9-4710-a68b-271575ceae2f | 2025-04-16 | Warnings | 214407 ANDA214407 |
| Rugby Mucus Relief D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Rugby Laboratories | ec947855-d77b-46ad-88bd-cf05b6ff004b | 2025-04-02 | Warnings | 214407 ANDA214407 |
| Leader Mucus Relief D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Cardinal Health 110, LLC. dba Leader | 919f5bf3-3b51-4450-9496-def940b3cb81 | 2025-03-10 | Warnings | 214407 ANDA214407 |
| Mucus D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Meijer, Inc. | 4a49c617-79d1-488c-a23f-7103c818b365 | 2025-01-07 | Warnings | 214407 ANDA214407 |
| foster and thrive mucus relief d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Strategic Sourcing Services LLC | 12460719-ff39-49b3-95f8-85e547ad0076 | 2024-11-21 | Warnings | 214407 ANDA214407 |
| Mucus Relief D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Walgreen Company | 915ca26a-d5d1-40f8-980d-415926e45656 | 2024-03-30 | Warnings | 214407 ANDA214407 |
| mucus relief d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | H E B | 0a2a2822-ea30-4a50-ad45-d85fd0431f95 | 2024-01-09 | Warnings | 214407 ANDA214407 |
| topcare mucus d | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | Topco Associates LLC | 02134afa-ae8c-4678-a19a-7fd3cab5782f | 2023-08-30 | Warnings | 214407 ANDA214407 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1305603 | guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | PSN | 0d5f6e14-5e42-494b-be1f-a46731007a0d | 2 |
| 1305603 | 12 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | SCD | 0d5f6e14-5e42-494b-be1f-a46731007a0d | 2 |
| 1305603 | guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG 12 HR Extended Release Oral Tablet | SY | 0d5f6e14-5e42-494b-be1f-a46731007a0d | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 79903-125-18 | 79903012518 | 1 BLISTER PACK in 1 CARTON (79903-125-18) > 18 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK | 1 blister pack | 2022-10-01 | 0000-00-00 | No | No | Current |